Hematoprotective effect of seleno-L-methionine on cyclophosphamide toxicity in rats

Drug and Chemical Toxicology

Volumn 32, Issue 4, 2009, Pages 424-428

  Ayhanci, Adnan ^a   Yaman, Suzan ^a   Appak, Sila ^b   Gunes, Sibel ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b IZMIR INSTITUTE OF TECHNOLOGY   (Turkey)

Author keywords

Cyclophosphamide; Cytoprotectivity; Hematoxicity; Rats; Seleno L methionine

Indexed keywords

CYCLOPHOSPHAMIDE; SELENOMETHIONINE; ALKYLATING AGENT; ANTIOXIDANT; GLUTATHIONE PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD TOXICITY; BODY WEIGHT; BONE MARROW TOXICITY; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; FEMALE; LEUKOCYTE COUNT; MALE; NONHUMAN; RAT; THROMBOCYTE COUNT; ANIMAL; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; FLOW CYTOMETRY; LEUKOCYTE; METABOLISM; METHODOLOGY; PATHOLOGY; SPRAGUE DAWLEY RAT; THROMBOCYTE;

ANIMALIA; RATTUS;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTIOXIDANTS; BLOOD PLATELETS; CELL TRANSFORMATION, NEOPLASTIC; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GLUTATHIONE PEROXIDASE; LEUKOCYTES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SELENOMETHIONINE;

EID: 74049114183     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540903130682     Document Type: Article

References (22)

1. Ayhanci, A., Uyar, R., Aral, E., Kabader, S., Appak, S. (2008). Protective effect of zinc on cyclophosphamide-induced hematoxicity and urotoxicity. Biol Trace Elem Res 126:186-193.
2. Anderson, D., Bishop, J. B., Garner, R. C., Ostrosky-Wegman, P., Selby, P. B. (1995). Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risk. Mutat Res 330:115-181.
3. Bergsagel, D. E., Roberson, G. L., Hasselback, R. (1968). Effect of cyclophosphamide on advanced lung cancer and haematological toxicity of large, intermittent intravenous doses. Can Med Assoc J 98:532-538.
4. Cao, S., Durrani, F. A., Rustum, Y. M. (2004). Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Cancer Res 10:2561-2569.
5. Fraiser, L. H., Kanekal, S., Kehrer, J. P. (1991). Cyclophosphamide toxicity: characterizing and avoiding the problem. Drugs 42:781-795.
6. George, K. S., Rajesh, R., Sunil Kumar, S., Sulekha, B., Balaram, P., (2008). A polyherbal ayurvedic drug-Indukantha Ghritham as an adjuvant to cancer chemotherapy via immunomodulation. Immunobiology 213:641-649.
7. Hoffmann, P. R., Berry, M. J. (2008). The influence of selenium on immune responses. Mol Nutr Res 52:1273-1280.
8. Jamba, L., Nehru, B., Bansal, M. P. (1997). Selenium supplementation during cadmium exposure: changes in antioxidant enzymes and the ultrastructure of the kidney. J Trace Elements Exp Med 10:233-242.
9. Kumar, K. B. H., Kuttan, R (2005). Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamideinduced toxicity in mice Phytomedicine 12:494-500.
10. Kumari, J., Shaoo, P. K. (2005). Effects of cyclophosphamide on the immune system and disease resistance of Asian catfish Clarias batrachus. Fish Shellfish Immunol 19: 307-316. (Pubitemid 40607832)
11. Langford, C. A. (1997). Complications of cyclophosphamide therapy. Eur Arch Otorhinolaringol 254:65-72.
12. Liang, J., Huang, M., Duan, W., Yu, X-Q., Zhou, S. (2007). Design of new oxazaphosphorine anticancer drugs. Curr Pharm Des 13:963-978.
13. Manda, K., Bhatia, A. L. (2003). Prophylactic action of melatonin against cyclophosphamide-induced oxidative stress in mice. Cell Biol Toxicol 19:367-372.
14. Nomura, A. M. Y., Lee, J., Stemmermann, G. N., Combs, G. F. (2000). Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomark Prev 9:883-887.
15. Olas, B., Wachowicz, B. (1997). Selenium in the cytotoxicity of cisplatin. Postepy Hyg Med Dos 51:95-108.
16. Schuurman, H. J., Smith, H. T., Cozzi, E. (2005). Tolerability of cyclophosphamide and methotrexate induction immunosuppression in nonhuman primates. Toxicology 213:1-12.
17. Selvakumar, E., Prahalathan, C., Sudharsan, P. T., Varalakshmi, P. (2006). Chemoprotective effect of lipoic acid against cyclophosphamide- induced changes in the rat sperm. Toxicology 217:71-78.
18. Shah, A. S., Wakade, A. S., Juvekar, A. R. (2008). Immunomodulatory activity of methanolic extract of Murraya koenigii (L) Spreng leaves. Ind J Exp Biol 46 (7): 505-509.
19. Sieja, K., Talerczyk, M. (2004). Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol 93:320-327.
20. Spallholz, J. E. (2003). Use of selenium to prevent and treat cancer in the new millennium. J Kor Assoc Cancer Prev 8:9-23.
21. Weijl, N. I., Elsendoorn, T. J., Lentjes, E. G., Hopman, G. D., Wipkink-Bakker, A., Zwinderman, A. H., et al. (2004). Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double- blind, placebo-controlled study. Eur J Cancer 40:1713-1723.
22. Zeng, H., Combs, J. G. F. (2008). Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19:1-7.